Loading news...
Investors love ultra-high-yield dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
Perrigo Company plc (PRGO) Presents at UBS Global Consumer and Retail Conference Transcript
Dimensional Fund Advisors LP raised its position in Perrigo Company plc (NYSE: PRGO) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,695,238 shares of the company's stock after buying an additional 181,828 shares during the period.
Citigroup Inc. raised its position in shares of Perrigo Company plc (NYSE: PRGO) by 110.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 89,197 shares of the company's stock after purchasing an additional 46,848 shares during the quarter. Citigroup
United-Guardian (NASDAQ: UG - Get Free Report) and Perrigo (NYSE: PRGO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Valuation and Earnings This table compares United-Guardian and Perrigo"s
What's better than getting to buy 6.6%-11% yields at discounted prices?
Shares of Perrigo Company plc (NYSE: PRGO - Get Free Report) have been assigned an average rating of "Hold" from the six analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating on
DUBLIN, Ireland, March 3, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor is scheduled to present at the UBS Global Consumer and Retail Conference, on Wednesday, March 11th at 11:00 AM EDT. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Perrigo misses Q4 EPS estimates. Its 2026 sales and profit estimates are below expectations as Infant Formula headwinds persist.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Perrigo Company plc (PRGO) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Perrigo (PRGO) came out with quarterly earnings of $0.77 per share, missing the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.93 per share a year ago.
Delivered FY2025 Adj. EPS at the Midpoint of Updated Outlook Range Advanced '3-S Plan' with Perrigo Store Brand OTC and Key Brands Gaining Share 1,2 in 2025, Despite Soft Category Consumption Launching New Operational Enhancement Program - Expected to Deliver Pre-Tax Annualized Savings of $80 million to $100 million Transitioning to New Reporting Segments Beginning Q1 2026, Aligned to Commercial Operating Model Issues FY2026 'All In' Outlook; Introduces FY2026 'CORE' Outlook, which Excludes Infant Formula and Previously Announced Divestitures Fourth Quarter 2025 YoY Highlights : Net Sales: $1.11 billion, -2.5% year-over-year as favorable FX +2.3% was more than offset by organic net sales -4.5% and the impact of divestitures and exited products -0.4%.
Get a deeper insight into the potential performance of Perrigo (PRGO) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in Perrigo (PRGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Investors aren't putting cash under their mattresses, but they're certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.